Unbiased AI-powered news
1 stories related to this topic, newest first.
agfundernews.comBiotalys announced its consolidated financial results for 2025 on April 29, 2026, showing year-end cash and cash equivalents of €8.0 million, sufficient until the end of May 2026. The company detailed regulatory approvals for its biofungicide EVOCA and progress on pipeline progra…